Sort
25,944 grants matching “neurodegeneration”
Rare Variant Whole Genome Analysis and iPSC Validation of Putative Genetic Modifiers of Huntington Disease
$643,796Steven M Finkbeiner · J. David Gladstone Institutes · R37 · FY2023 · NS
Rare Variant Whole Genome Analysis and iPSC Validation of Putative Genetic Modifiers of Huntington Disease
$643,795Steven M Finkbeiner · J. David Gladstone Institutes · R37 · FY2020 · NS
Allosteric regulation of SIRT1 by a PACS-2 and DBC1 regulatory hub
$643,772Angela M. Gronenborn · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DK
Neuroprotection by IFN-beta in AIDS
$643,693Marcus Kaul · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2016 · MH
A Beta Vaccination: Mechanisms and Therapautic Impact
$643,533J. David Gladstone Institutes · R01 · FY2004 · NS
Epigenetic-Genetic Modulations in Aging and Alzheimer's Disease Neurons
$643,399Evgeny I Rogaev · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · AG
Deciphering the molecular interplay of sleep and neurodegeneration with Drosophila
$643,393Matthew S Kayser · University Of Pennsylvania · R01 · FY2022 · AG
Cellular Mechanisms of Enteric Nervous System Damage in CLN2 Disease
$643,377Jonathan D Cooper · Washington University · R01 · FY2025 · NS
Precision Medicine for Inherited Retinal Degenerations
$643,375Eric A Pierce · Massachusetts Eye And Ear Infirmary · R01 · FY2021 · EY
MRI predictors of disease and disability progression in African Americans with multiple sclerosis
$643,285Fred D Lublin · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · NS
Small molecule Parkin activators to treat Alzheimer's Disease
$643,048Kumar Suresh · Progenra, Inc. · R44 · FY2018 · AG
LRRK2 and inflammasome pathway in Parkinson's disease
$642,851Wanli W Smith · Johns Hopkins University · R01 · FY2023 · NS
Air Pollution, the Aging Brain and Alzheimer's Disease
$642,597Gail Li · University Of Washington · R01 · FY2017 · ES
Core A: Administrative Core
$642,584Douglas R Galasko · University Of California, San Diego · P50 · FY2015 · AG
Microbiota-targeted approaches to resolve dysbiosis-induced AD neuropathology following brain injury.
$642,579Sonia Villapol · Methodist Hospital Research Institute · R56 · FY2023 · AG
Neurosteroid Treatment for OP Intoxication
$642,562Doodipala Samba Reddy · Texas A&M University Health Science Ctr · U01 · FY2017 · NS
Antisense Oligonucleotides targeting APP to prevent neurodegeneration in models of Down Syndrome and Alzheimer's disease
$642,516William C Mobley · University Of California, San Diego · R01 · FY2023 · AG
Neural Mechanisms for Associations Between Fitness and Cognition in Aging
$642,493Jerome Carson Smith · Univ Of Maryland, College Park · R56 · FY2023 · AG
White matter and small vessel disease in older adults
$642,445Angela L. Jefferson · Vanderbilt University Medical Center · R01 · FY2020 · AG
White matter and small vessel disease in older adults
$642,445Angela L. Jefferson · Vanderbilt University Medical Center · R01 · FY2019 · AG
Neuroimaging Core
$642,164John A Detre · University Of Pennsylvania · P30 · FY2024 · AG
CAA, Tau and Neurodegeneration
$642,064Cristian Lasagna-Reeves · Indiana University Indianapolis · R01 · FY2020 · AG
Single Cell Analyses of Neuroimmune Dysfunctions in the Thalamocortical Circuit in FTLD
$642,000Eric J Huang · University Of California, San Francisco · R01 · FY2019 · AA
Neuronal and vascular interactions in the CNS
$641,842Chenghua Gu · Harvard Medical School · R01 · FY2020 · HL
Mitochondrial Complex III Free Radicals in Dementia-Related Proteinopathy and Neuroinflammation
$641,613Anna Goldshmidt Orr · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AG